Annual FCF:
$468.37M+$95.09M(+25.47%)Summary
- As of today, HALO annual free cash flow is $468.37 million, with the most recent change of +$95.09 million (+25.47%) on December 31, 2024.
- During the last 3 years, HALO annual free cash flow has risen by +$170.38 million (+57.18%).
- HALO annual free cash flow is now at all-time high.
Performance
HALO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
$98.15M-$55.12M(-35.96%)Summary
- As of today, HALO quarterly free cash flow is $98.15 million, with the most recent change of -$55.12 million (-35.96%) on June 30, 2025.
- Over the past year, HALO quarterly free cash flow has increased by +$44.94 million (+84.45%).
- HALO quarterly free cash flow is now -44.05% below its all-time high of $175.41 million, reached on December 31, 2024.
Performance
HALO Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$540.69M+$44.94M(+9.06%)Summary
- As of today, HALO TTM free cash flow is $540.69 million, with the most recent change of +$44.94 million (+9.06%) on June 30, 2025.
- Over the past year, HALO TTM free cash flow has increased by +$132.37 million (+32.42%).
- HALO TTM free cash flow is now at all-time high.
Performance
HALO TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
HALO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +25.5% | +84.5% | +32.4% |
| 3Y3 Years | +57.2% | +150.0% | +86.3% |
| 5Y5 Years | +623.5% | +3431.8% | +2397.2% |
HALO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +99.0% | -44.0% | +84.5% | at high | +129.8% |
| 5Y | 5-Year | at high | +623.5% | -44.0% | +1561.3% | at high | +2397.2% |
| All-Time | All-Time | at high | +623.5% | -44.0% | +419.8% | at high | +704.4% |
HALO Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $98.15M(-36.0%) | $540.69M(+9.1%) |
| Mar 2025 | - | $153.27M(-12.6%) | $495.76M(+5.8%) |
| Dec 2024 | $468.37M(+25.5%) | $175.41M(+54.1%) | $468.37M(+19.3%) |
| Sep 2024 | - | $113.86M(+114.0%) | $392.71M(-3.8%) |
| Jun 2024 | - | $53.21M(-57.7%) | $408.32M(-3.6%) |
| Mar 2024 | - | $125.88M(+26.2%) | $423.57M(+13.5%) |
| Dec 2023 | $373.28M(+58.6%) | $99.76M(-22.9%) | $373.28M(+5.6%) |
| Sep 2023 | - | $129.47M(+89.1%) | $353.63M(+20.8%) |
| Jun 2023 | - | $68.47M(-9.4%) | $292.79M(+11.1%) |
| Mar 2023 | - | $75.59M(-5.6%) | $263.58M(+12.0%) |
| Dec 2022 | $235.30M(-21.0%) | $80.11M(+16.7%) | $235.30M(-0.9%) |
| Sep 2022 | - | $68.63M(+74.8%) | $237.55M(-18.1%) |
| Jun 2022 | - | $39.26M(-17.0%) | $290.17M(+1.0%) |
| Mar 2022 | - | $47.31M(-42.6%) | $287.26M(-3.6%) |
| Dec 2021 | $297.98M(+462.8%) | $82.36M(-32.1%) | $297.98M(+12.5%) |
| Sep 2021 | - | $121.24M(+233.5%) | $264.85M(+77.1%) |
| Jun 2021 | - | $36.36M(-37.3%) | $149.51M(+29.0%) |
| Mar 2021 | - | $58.03M(+17.9%) | $115.93M(+118.9%) |
| Dec 2020 | $52.95M(+159.2%) | $49.22M(+733.1%) | $52.95M(+325.0%) |
| Sep 2020 | - | $5.91M(+112.6%) | -$23.54M(+60.9%) |
| Jun 2020 | - | $2.78M(+156.1%) | -$60.14M(+32.5%) |
| Mar 2020 | - | -$4.96M(+81.8%) | -$89.07M(+0.4%) |
| Dec 2019 | -$89.46M(-65.2%) | -$27.27M(+11.2%) | -$89.46M(-63.2%) |
| Sep 2019 | - | -$30.69M(-17.4%) | -$54.81M(-26.4%) |
| Jun 2019 | - | -$26.15M(-388.8%) | -$43.38M(-18.8%) |
| Mar 2019 | - | -$5.35M(-172.4%) | -$36.50M(+32.6%) |
| Dec 2018 | -$54.16M(-140.8%) | $7.39M(+138.4%) | -$54.16M(-159.6%) |
| Sep 2018 | - | -$19.26M(+0.1%) | $90.84M(-30.2%) |
| Jun 2018 | - | -$19.28M(+16.2%) | $130.19M(-1.6%) |
| Mar 2018 | - | -$23.02M(-115.1%) | $132.25M(-0.3%) |
| Dec 2017 | $132.70M(+348.0%) | $152.39M(+658.2%) | $132.70M(+469.6%) |
| Sep 2017 | - | $20.10M(+216.7%) | -$35.90M(+44.9%) |
| Jun 2017 | - | -$17.23M(+23.6%) | -$65.17M(-5.2%) |
| Mar 2017 | - | -$22.56M(-39.1%) | -$61.96M(-15.8%) |
| Dec 2016 | -$53.52M(-35.7%) | -$16.21M(-76.8%) | -$53.52M(+1.1%) |
| Sep 2016 | - | -$9.17M(+34.5%) | -$54.14M(+13.1%) |
| Jun 2016 | - | -$14.01M(+0.8%) | -$62.29M(-57.3%) |
| Mar 2016 | - | -$14.12M(+16.1%) | -$39.60M(-0.4%) |
| Dec 2015 | -$39.44M(+19.3%) | -$16.83M(+2.8%) | -$39.44M(-65.8%) |
| Sep 2015 | - | -$17.32M(-299.6%) | -$23.79M(-18.8%) |
| Jun 2015 | - | $8.68M(+162.1%) | -$20.02M(+55.3%) |
| Mar 2015 | - | -$13.97M(-1088.9%) | -$44.81M(+8.3%) |
| Dec 2014 | -$48.89M(+5.3%) | -$1.18M(+91.3%) | -$48.89M(+24.0%) |
| Sep 2014 | - | -$13.55M(+15.9%) | -$64.29M(-1.3%) |
| Jun 2014 | - | -$16.12M(+10.7%) | -$63.47M(-8.7%) |
| Mar 2014 | - | -$18.04M(-8.8%) | -$58.39M(-13.1%) |
| Dec 2013 | -$51.64M | -$16.58M(-30.1%) | -$51.64M(+1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$12.74M(-15.4%) | -$52.47M(+3.2%) |
| Jun 2013 | - | -$11.04M(+2.2%) | -$54.19M(+5.9%) |
| Mar 2013 | - | -$11.28M(+35.2%) | -$57.62M(+12.3%) |
| Dec 2012 | -$65.69M(-87.0%) | -$17.41M(-20.3%) | -$65.69M(-5.4%) |
| Sep 2012 | - | -$14.47M(-0.0%) | -$62.34M(-1.6%) |
| Jun 2012 | - | -$14.46M(+25.3%) | -$61.36M(-42.1%) |
| Mar 2012 | - | -$19.36M(-37.7%) | -$43.19M(-23.0%) |
| Dec 2011 | -$35.13M(+23.7%) | -$14.06M(-4.3%) | -$35.13M(-22.1%) |
| Sep 2011 | - | -$13.48M(-463.5%) | -$28.77M(-6.7%) |
| Jun 2011 | - | $3.71M(+132.8%) | -$26.97M(+39.5%) |
| Mar 2011 | - | -$11.30M(-46.6%) | -$44.58M(+3.2%) |
| Dec 2010 | -$46.03M(-10.6%) | -$7.71M(+34.0%) | -$46.03M(+7.7%) |
| Sep 2010 | - | -$11.68M(+16.0%) | -$49.86M(+5.6%) |
| Jun 2010 | - | -$13.90M(-9.0%) | -$52.81M(-5.1%) |
| Mar 2010 | - | -$12.75M(-10.6%) | -$50.26M(-20.8%) |
| Dec 2009 | -$41.61M(-13.9%) | -$11.53M(+21.2%) | -$41.61M(-5.7%) |
| Sep 2009 | - | -$14.63M(-29.0%) | -$39.37M(-10.0%) |
| Jun 2009 | - | -$11.35M(-176.8%) | -$35.80M(-2.5%) |
| Mar 2009 | - | -$4.10M(+55.9%) | -$34.92M(+4.4%) |
| Dec 2008 | -$36.53M(-1353.8%) | -$9.29M(+16.0%) | -$36.53M(-3.1%) |
| Sep 2008 | - | -$11.06M(-5.7%) | -$35.45M(-74.4%) |
| Jun 2008 | - | -$10.47M(-83.2%) | -$20.32M(-42.7%) |
| Mar 2008 | - | -$5.71M(+30.4%) | -$14.24M(-466.8%) |
| Dec 2007 | -$2.51M(-137.4%) | -$8.21M(-301.9%) | -$2.51M(-111.6%) |
| Sep 2007 | - | $4.07M(+192.7%) | $21.74M(+47.7%) |
| Jun 2007 | - | -$4.39M(-172.9%) | $14.72M(-5.5%) |
| Mar 2007 | - | $6.02M(-62.5%) | $15.57M(+131.9%) |
| Dec 2006 | $6.71M(+150.3%) | $16.05M(+643.1%) | $6.71M(+151.9%) |
| Sep 2006 | - | -$2.95M(+16.5%) | -$12.94M(+3.9%) |
| Jun 2006 | - | -$3.54M(-24.5%) | -$13.46M(-3.6%) |
| Mar 2006 | - | -$2.84M(+21.3%) | -$13.00M(+2.6%) |
| Dec 2005 | -$13.35M(-68.0%) | -$3.61M(-3.9%) | -$13.35M(-5.4%) |
| Sep 2005 | - | -$3.48M(-13.1%) | -$12.66M(-7.8%) |
| Jun 2005 | - | -$3.07M(+3.6%) | -$11.74M(-15.0%) |
| Mar 2005 | - | -$3.19M(-9.1%) | -$10.21M(-28.5%) |
| Dec 2004 | -$7.95M(>-9900.0%) | -$2.92M(-14.2%) | -$7.95M(-95.6%) |
| Sep 2004 | - | -$2.56M(-65.8%) | -$4.06M(-156.3%) |
| Jun 2004 | - | -$1.54M(-67.5%) | -$1.59M(-121.8%) |
| Mar 2004 | - | -$920.90K(-195.9%) | $7.26M(>+9900.0%) |
| Dec 2003 | -$49.70K(+10.9%) | $960.40K(+1275.5%) | -$49.70K(+95.3%) |
| Sep 2003 | - | -$81.70K(-101.1%) | -$1.05M(-7.3%) |
| Jun 2003 | - | $7.30M(+188.7%) | -$978.40K(+88.2%) |
| Mar 2003 | - | -$8.23M(>-9900.0%) | -$8.27M(>-9900.0%) |
| Dec 2002 | -$55.80K(-62.2%) | -$39.50K(-276.2%) | -$55.70K(-243.8%) |
| Sep 2002 | - | -$10.50K(-252.2%) | -$16.20K(-184.2%) |
| Jun 2002 | - | $6900.00(+154.8%) | -$5700.00(+54.8%) |
| Mar 2002 | - | -$12.60K | -$12.60K |
| Dec 2001 | -$34.40K | - | - |
FAQ
- What is Halozyme Therapeutics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. annual free cash flow year-on-year change?
- What is Halozyme Therapeutics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. quarterly free cash flow year-on-year change?
- What is Halozyme Therapeutics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. TTM free cash flow year-on-year change?
What is Halozyme Therapeutics, Inc. annual free cash flow?
The current annual free cash flow of HALO is $468.37M
What is the all-time high annual free cash flow for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high annual free cash flow is $468.37M
What is Halozyme Therapeutics, Inc. annual free cash flow year-on-year change?
Over the past year, HALO annual free cash flow has changed by +$95.09M (+25.47%)
What is Halozyme Therapeutics, Inc. quarterly free cash flow?
The current quarterly free cash flow of HALO is $98.15M
What is the all-time high quarterly free cash flow for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high quarterly free cash flow is $175.41M
What is Halozyme Therapeutics, Inc. quarterly free cash flow year-on-year change?
Over the past year, HALO quarterly free cash flow has changed by +$44.94M (+84.45%)
What is Halozyme Therapeutics, Inc. TTM free cash flow?
The current TTM free cash flow of HALO is $540.69M
What is the all-time high TTM free cash flow for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high TTM free cash flow is $540.69M
What is Halozyme Therapeutics, Inc. TTM free cash flow year-on-year change?
Over the past year, HALO TTM free cash flow has changed by +$132.37M (+32.42%)